Tumor Molecular Profiling gives an overview of the genomic landscape of tumors and how that information is being used to tailor treatments and manage patients.
We'll cover the molecular basis of cancer, technological and therapeutic advances, and how genetic testing is being used across the cancer clinical spectrum.
Who should take this course
Tumor Molecular Profiling was designed to educate lay professional audiences working in both clinical and non-clinical settings. This course is for:
- Physicians, nurses and other health care providers in oncology
- Tool and test developers in the genomics space
- Health information, software and other technology companies
- Insurance companies who want to understand how to value tumor profiling tests
This course is available for a one time fee of $245.00
What you’ll get from the course
This course consists of:
- Six short didactic videos (total watch time ~45 minutes)
- An active discussion forum
- Enduring materials (slides to download)
Please note: We recommend that students taking the Tumor Molecular Profiling course have a basic understanding of human genetics before enrolling. If you don’t have a background in genetics – or if you want a quick refresser - consider taking our free online course: PM101: Human Genomics (~30 min)
What You'll Learn
What is cancer; mutational landscape of tumors; cancer driver genes; somatic vs germline variation in cancer.
Targeted Cancer Treatment
Targeted treatments and companion diagnostics; tissue agnostic treatments; indications; expanded treatment options; barriers to clinical trials.
Tumor Molecular Profiling and its Technical Challenges
Panel sizes; Tumor heterogeneity; discerning somatic vs. germline.
Immune system in cancer; checkpoint inhibitors, cancer vaccines, CAR-T cell therapy, immunotherapy diagnostics.
Circulating tumor DNA by stage and type of cancer; commercial landscape.
Clinical Applications of Cancer Genetics
Predisposition testing; screening/early diagnosis; prognosis; treatment selection/efficacy; disease monitoring.
The information provided through this course is for educational purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.
All materials are copyrighted. Republication or redistribution of PMA content is prohibited without prior written consent. PMA shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Jeanette McCarthy has been a leading educator in the field of precision medicine for over a decade. She’s designed and delivered dozens of online courses and in-person workshops to healthcare providers, consumers, diagnostic companies, health IT companies, investors and others worldwide.
Dr. McCarthy spent the early part of her career as a molecular epidemiologist at Millennium Pharmaceuticals and in academia, and currently holds adjunct faculty positions at Duke University and the University of California - San Francisco (UCSF). She is the co-author of Precision Medicine: A Guide to Genomics in Clinical Practice, and served as editor-in-chief of Genome, the first magazine dedicated to educating consumers about the promise and challenges of genomic medicine.
Dr. McCarthy is the founder of Precision Medicine Advisors, which brings healthcare organizations, health care providers, diagnostic test developers, health IT companies, investors and others up to speed on the availability, value and limitations of genetic tests on the market and in development.